Meredith Hargus is an access leader with over 25 years of experience in launch strategy and patient support program management across rare disease, oncology and specialty therapeutics. Meredith built and led the US patient support organization at Argenx to launch a novel autoimmune therapy in gMG. She directed patient access programs across the Takeda Oncology portfolio, launching three oral agents over 5 years within the Patient Value and Access team. Prior to this Meredith spent 9 years at Sanofi-Genzyme where she led payer access strategy for rare disease products. Meredith started her career at Covance where she designed and managed patient support programs in neurology, oncology and nephrology.